Showing results (401-410 of 466) with videos related to
Sort By:
Pageof 47
British Journal of Rheumatology|September 1, 1994
Bone density of normal women in relation to endogenous and exogenous oestrogensI S Fentiman, D Y Wang, D S Allen, et al.Breast Cancer Research and Treatment|April 1, 1997
Breast cancer risk is positively associated with heightD Y Wang, B L DeStavola, D S Allen, et al.International Journal of Cancer|August 15, 1986
A comparison of the in vivo uptake and metabolism of 3H-oestrone and 3H-oestradiol by normal breast and breast tumour tissues in post-menopausal womenJ M McNeill, M J Reed, P A Beranek, et al.British Journal of Cancer|April 12, 2007
In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiolS K Chander, P A Foster, M P Leese, et al.Diabetologia|November 13, 2007
No evidence that established type 2 diabetes susceptibility variants in the PPARG and KCNJ11 genes have pleiotropic effects on early growthA J Bennett, U Sovio, A Ruokonen, et al.Progress in Growth Factor Research|January 1, 1995
Tissue IGFBP-3 proteolysis: contrasting pathophysiology to that in the circulationS C Hughes, S Xu, J Fernihough, et al.Human Reproduction (Oxford, England)|September 1, 2017
Dormancy and activation of human oocytes from primordial and primary follicles: molecular clues to oocyte regulationE H Ernst, M L Grøndahl, S Grund, et al.Anti-Cancer Drug Design|June 7, 2002
Inhibition of superoxide dismutase by 2-methoxyoestradiol analogues and oestrogen derivatives: structure-activity relationshipsL Wood, M R Leese, B Leblond, et al.The Journal of Steroid Biochemistry and Molecular Biology|May 3, 2005
The effects of 2-methoxyoestrogen sulphamates on the in vitro and in vivo proliferation of breast cancer cellsT Utsumi, M P Leese, S K Chander, et al.British Journal of Cancer|August 26, 2004
Pharmacokinetics of the nonsteroidal steroid sulphatase inhibitor 667 COUMATE and its sequestration into red blood cells in ratsC R Ireson, S K Chander, A Purohit, et al.Pageof 47